Amalgamated Bank’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Amalgamated Bank’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,347	Closed	-$146K	–	2989
2023 Q4	$146K	Buy	+2,347	New	+$58.3K	﹤0.01%	1889

Amalgamated Bank's RYZB Position: Q1 2024 in Review

Amalgamated Bank sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 2,347 shares — an estimated $146K sold.

Amalgamated Bank first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $146K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Amalgamated Bank reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Amalgamated Bank sold 2,347 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $146K.
Amalgamated Bank first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Amalgamated Bank's RayzeBio, Inc. Common Stock position peaked at $146K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Amalgamated Bank's 13F filing for Q1 2024, filed 23 Apr 2024.